AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2021
May 19, 2021
34491_dirs_2021-05-19_936f4e71-31df-421f-a383-48a9fce49dd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-05-17
Reporting Person: JANTZ DEREK (Director, Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-17 | Common Stock | S | 20000 | $9.38 | Disposed | 4032279 | Direct |
Footnotes
F1: The sale was effected to cover the taxes incurred with the Reporting Person's previous option exercise.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.21 to $9.63. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.